Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-128656
Filing Date
2016-06-17
Accepted
2016-06-17 17:20:53
Documents
1
Period of Report
2016-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3981
  Complete submission text file 0001209191-16-128656.txt   5573
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Issuer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9 DEER PARK DRIVE SUITE C MONMOUTH JUNCTION NJ 08852
Business Address
Pauls Matthew (Reporting) CIK: 0001573429 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32157 | Film No.: 161720909